Skip to content

Life Sciences

Multi-Stage HEPA/ULPA Filtration

  • Life Sciences
  • 1 min read

Multi-Stage HEPA/ULPA Filtration: A Key Barrier for Contamination Control in Pharma

In pharmaceutical manufacturing, clean air is not optional – it’s essential for product quality, sterility, and GMP compliance.

Multi-stage filtration systems play a critical role by removing airborne particles step by step:

  • Pre-Filters – capture large dust and protect downstream filters.
  • Fine Filters – reduce smaller particulates and extend HEPA life.
  • HEPA Filters (H13/H14) – standard for cleanrooms, removing ≥99.95% of particles.
  • ULPA Filters – ultra-high efficiency for aseptic filling and advanced biologics.

Why it matters:

  • Stronger contamination control.
  • Support for ISO 14644 & EU GMP Annex 1 requirements.
  • Longer filter lifecycle and lower operating costs.
  • Improved sterility assurance in critical production zones.

As pharma moves toward biologics and high-potency therapies, HEPA/ULPA filtration remains the backbone of cleanroom safety.

Industries

Related

More on this subject

Periodic requalification: what is retested and how often

EU GMP Annex 1 (2022) sets maximum requalification intervals: 6 months for Grade A and B cleanrooms and 12 months for Grade C and D. Classification, HEPA leak tests, airflow volume, pressure differentials and air velocity, or recovery where airflow is not unidirectional, are retested. A risk assessment can shorten these intervals, never extend them.

InsightRead

What ends the life of a HEPA filter

EU GMP Annex 1 (2022) asks for an integrity test of final filters at requalification and puts no age on the filter. A terminal HEPA is replaced when a leak cannot be repaired within site limits, when pressure drop reaches the manufacturer's final value, or after damage or wetting. On glass-fibre media, dust loading alone does not lower efficiency.

InsightRead